Invesco
CTSO icon

Invesco’s Cytosorbents Corp CTSO Stock Holding History

Invesco’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-695
Closed -$44K – 4060
2022
Q1 		$44K Sell
695
-17
-2% -$1.22K ﹤0.01% 3939
2021
Q4 		$60K Sell
712
-20
-3% -$2.24K ﹤0.01% 3961
2021
Q3 		$119K Buy
732
+180
+33% +$29.2K ﹤0.01% 3906
2021
Q2 		$83K Sell
552
-227
-29% -$38.3K ﹤0.01% 3917
2021
Q1 		$136K Buy
+779
New +$148K ﹤0.01% 3726
2019
Q2 		– Sell
-1,391
Closed -$211K – 3731
2019
Q1 		$211K Sell
1,391
-215
-13% -$33.5K ﹤0.01% 3611
2018
Q4 		$259K Sell
1,606
-9,489
-86% -$1.88M ﹤0.01% 3494
2018
Q3 		$2.86M Buy
11,095
+9,549
+618% +$2.39M ﹤0.01% 2514
2018
Q2 		$353K Buy
+1,546
New +$293K ﹤0.01% 3541

Other funds holding CTSO

Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco's CTSO Position: Q2 2022 in Review

Invesco sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 695 shares — an estimated $44K sold.

Invesco first reported a position in CTSO in Q2 2018 and held it in 9 quarters. The position peaked at $2.86M in Q3 2018. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

  • Invesco reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 695 Cytosorbents Corp shares in Q2 2022, an estimated $44K.
  • Invesco first reported a position in Cytosorbents Corp in Q2 2018 and held it in 9 quarters.
  • Invesco's Cytosorbents Corp position peaked at $2.86M in Q3 2018.
  • 78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.